Background: Cancer centers have a responsibility to help patients manage the costs of their cancer treatment. This article describes the availability of financial navigation services within the National Cancer Institute (NCI)-designated cancer centers. Methods: Data were obtained from the NCI Survey of Financial Navigation Services and Research, an online survey administered to NCI-designated cancer centers from July to September 2019. Of the 62 eligible centers, 57 completed all or most of the survey, for a response rate of 90.5%. Results: Nearly all cancer centers reported providing help with applications for pharmaceutical assistance programs and medical discounts (96.5%), health insurance coverage (91.2%), assistance with nonmedical costs (96.5%), and help understanding medical bills and out-of-pocket costs (85.9%). Although other services were common, in some cases they were only available to certain patients. These services included direct financial assistance with medical and nonmedical costs and referrals to outside organizations for financial assistance. The least common services included medical debt management (63.2%), detailed discussions about the cost of treatment (54.4%), and guidance about legal protections (50.1%). Providing treatment cost transparency to patients was reported as a common challenge: 71.9% of centers agreed or strongly agreed that it is difficult to determine how much a cancer patient's treatment will cost, and 70.2% of oncologists are reluctant to discuss financial issues with patients. Conclusions: Cancer centers provide many financial services and resources. However, there remains a need to build additional capacity to deliver comprehensive financial navigation services and to understand the extent to which patients are referred and helped by these services. Published by Oxford University Press 2021. This work is written by US Government employees and is in the public domain in the US.
Background: Cancer centers have a responsibility to help patients manage the costs of their cancer treatment. This article describes the availability of financial navigation services within the National Cancer Institute (NCI)-designated cancer centers. Methods: Data were obtained from the NCI Survey of Financial Navigation Services and Research, an online survey administered to NCI-designated cancer centers from July to September 2019. Of the 62 eligible centers, 57 completed all or most of the survey, for a response rate of 90.5%. Results: Nearly all cancer centers reported providing help with applications for pharmaceutical assistance programs and medical discounts (96.5%), health insurance coverage (91.2%), assistance with nonmedical costs (96.5%), and help understanding medical bills and out-of-pocket costs (85.9%). Although other services were common, in some cases they were only available to certain patients. These services included direct financial assistance with medical and nonmedical costs and referrals to outside organizations for financial assistance. The least common services included medical debt management (63.2%), detailed discussions about the cost of treatment (54.4%), and guidance about legal protections (50.1%). Providing treatment cost transparency to patients was reported as a common challenge: 71.9% of centers agreed or strongly agreed that it is difficult to determine how much a cancer patient's treatment will cost, and 70.2% of oncologists are reluctant to discuss financial issues with patients. Conclusions: Cancer centers provide many financial services and resources. However, there remains a need to build additional capacity to deliver comprehensive financial navigation services and to understand the extent to which patients are referred and helped by these services. Published by Oxford University Press 2021. This work is written by US Government employees and is in the public domain in the US.
Authors: Matthew P Banegas; Jennifer L Schneider; Alison J Firemark; John F Dickerson; Erin E Kent; Janet S de Moor; Katherine S Virgo; Gery P Guy; Donatus U Ekwueme; Zhiyuan Zheng; Alexandra M Varga; Lisa A Waiwaiole; Stephanie M Nutt; Aditi Narayan; K Robin Yabroff Journal: J Cancer Surviv Date: 2019-05-23 Impact factor: 4.442
Authors: Ya-Chen Tina Shih; Fabrice Smieliauskas; Daniel M Geynisman; Ronan J Kelly; Thomas J Smith Journal: J Clin Oncol Date: 2015-05-18 Impact factor: 44.544
Authors: Janet S de Moor; Angela B Mariotto; Carla Parry; Catherine M Alfano; Lynne Padgett; Erin E Kent; Laura Forsythe; Steve Scoppa; Mark Hachey; Julia H Rowland Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-03-27 Impact factor: 4.254
Authors: S Yousuf Zafar; Fumiko Chino; Peter A Ubel; Christel Rushing; Gregory Samsa; Ivy Altomare; Jonathan Nicolla; Deborah Schrag; James A Tulsky; Amy P Abernethy; Jeffery M Peppercorn Journal: Am J Manag Care Date: 2015-09 Impact factor: 2.229
Authors: Stacie B Dusetzina; Aaron N Winn; Gregory A Abel; Haiden A Huskamp; Nancy L Keating Journal: J Clin Oncol Date: 2013-12-23 Impact factor: 44.544
Authors: Katherine A Yeager; Whitney E Zahnd; Jan M Eberth; Robin C Vanderpool; Catherine Rohweder; Randall Teal; Maihan Vu; Lindsay Stradtman; Elizabeth L Frost; Erika Trapl; Sarah Koopman Gonzalez; Thuy Vu; Linda K Ko; Allison Cole; Paige E Farris; Jackilen Shannon; Natoshia Askelson; Laura Seegmiller; Arica White; Jean Edward; Melinda Davis; Victoria Petermann; Stephanie B Wheeler Journal: J Cancer Surviv Date: 2022-01-26 Impact factor: 4.062
Authors: Sarah H Nash; Julia Dilley; Claire Siekaniec; David O'Brien; Rosa Avila; Jessica Quinn Journal: Cancer Causes Control Date: 2022-10-02 Impact factor: 2.532
Authors: Stephanie B Wheeler; Caitlin B Biddell; Michelle L Manning; Mindy S Gellin; Neda R Padilla; Lisa P Spees; Cynthia D Rogers; Julia Rodriguez-O'Donnell; Cleo Samuel-Ryals; Sarah A Birken; Katherine E Reeder-Hayes; Victoria M Petermann; Allison M Deal; Donald L Rosenstein Journal: Trials Date: 2022-10-03 Impact factor: 2.728